The top 20 pharmaceutical companies have implemented a raft of new initiatives in the last two years. Yet in two important areas, progress remains static.

› Go to Key Findings

The industry pipeline is concentrated on five diseases. Five companies are developing more than half the products for developing countries.

› Go to Key Findings

Half of the companies in the Index are developing medicines tailored for children, with 7% of the overall research pipeline being devoted to “child-size” medicine.

› Go to Key Findings

More companies are tailoring their prices to different segments of national populations.

› Go to Key Findings

Home

New study

Download the report

Download the report

2014 Index Ranking

Latest News

Dialogue on Access to Medicine with Japanese pharma companies

8 January 2016 |

From 12 to 15 January, the Access to Medicine Foundation will be visiting Tokyo, Japan for a series of meetings with Japan-based pharmaceutical companies and other key stakeholders working towards improving access to medicine wo

› Read more

A new catalyst for change: methodology for the first Access to Vaccines Index

1 December 2015 |
The Access to Medicine Foundation is introducing a new tool for action – the Access to Vaccines Index. It will analyse how vaccine companies are improving access to high-priority vaccines for communities in need. › Read more

WHO Bulletin publishes Foundation's latest research: how big pharma addresses access to hepatitis C drugs

24 November 2015 |

The Bulletin of the World Health Organization has published the latest study from the Access to Medicine Foundation: on how the world’s largest pharma companies are improving access to hepatitis C treatment.

› Read more

Pharmaceutical companies come to Amsterdam: workshop on latest Index methodology

17 November 2015 |

On 18 and 19 November, the Access to Medicine Foundation will run a workshop in Amsterdam for 20 of the world’s largest pharmaceutical companies with a role to play in improving access to medicine.

› Read more

2016 Access to Medicine Index to place high emphasis on how pharmaceutical companies perform

29 October 2015 |
The Access to Medicine Foundation has published its latest methodology for benchmarking pharma companies on their efforts to improve access to medicine. The methodology for the 2016 Access to Medicine Index places greater emphasis on company performance.› Read more

What Leaders Say

Dr. Margaret Chan
Director-General, World Health Organization
"The Access to Medicine Index is a very important project. What gets measured, gets done."
Bill Gates
Chairman of Microsoft Corporation, Co-Chair and Trustee of the Bill & Melinda Gates Foundation
"When I talk to executives from pharmaceutical companies they tell me that they want to do more for neglected diseases, but they at least need to get credit for it. The Access to Medicine Index does exactly that."
Justine Greening
Justine Greening
The Rt Hon Justine Greening MP, Secretary of State for International Development, UK
This year’s index shows that the pharmaceutical industry has made progress in improving access to vital medicines for the globe’s poorest people, helping to tackle some of the world’s worst diseases. The deadly Ebola outbreak reminds us that there is still much to be done to stop the spread of diseases in developing countries.
Lilianne Ploumen
Minister for Foreign Trade and Development Cooperation, the Netherlands
“The Access to Medicine Index mobilizes the strength of the private sector, impacting the lives of millions of the most vulnerable people on earth. It showcases the synergy of aid, trade and investment.”
Knut Kjaer
Former CEO of RiskMetrics Group, Former CEO of Norges Bank Investment Management (NBIM) (1997-2007)
"Companies are beginning to understand that the value of corporate social responsibility programmes is not only the opportunity to do the right thing but that it's good for business as well. The Access to Medicine Index provides companies with a chance to improve performance and explore new business models while helping societies in need."

In the Media

Tara Prasad interviewed on the Zika virus on the BBC World Business Report.

26 January 2016 |

Talking to World Business Report on the BBC World Service, Research Programme Manager Tara Prasad discusses the Zika virus, the situation surrounding the development of a vaccine for it, its potential impact and affordability.

› Read more

Dutch TV show Koffietijd broadcasts interview with Suzanne Wolf on access to vaccines for children

6 January 2016 |

Suzanne Wolf, Director of Communications at the Access to Medicine Foundation, talks with Dutch TV presenter Pernille La Lau on Koffietijd (Coffeetime), about how vaccines save lives and protect children from the threat of disease.

› Read more

Wim Leereveld’s interview in the Achmea book titled - 2025: Hoe ziet de economie van Nederland er in 2025 uit.

6 January 2016 |

In attempting to foresee what the future holds for the Dutch economy, Achmea interviewed 29 thought leaders in the Netherlands. Wim Leereveld was one of these 29 thought leaders. In his interview, Wim speaks about the measurable impact that companies have on society.

› Read more

Jayasree K. Iyer talks about the Access to Medicine Index and the performance of Pharma companies in the 2014 Index with Pharmafile.

22 December 2015 |

Jayasree K. Iyer, Executive Director at the Access to Medicine Foundation discusses the Access to Medicine Index in Pharmafile.

› Read more

‘A New Day at the Access to Medicine Foundation’. Jayasree K. Iyer discusses the Access to Medicine Index and trends with FSG.

21 December 2015 |

Jaysree K. Iyer, Executive Director at the Access to Medicine Foundation discusses the Access to Medicine Index, the role of shared value champions, how the Index is changing the pharmaceutical landscape, and what trends she’s most excited about around access to medicine.

› Read more